শেষ আপডেট: সেপ্টেম্বর 2, 2026

This past May I walked the corridors of the American Urological Association (AUA) 2026 Annual Meeting in Washington, DC, shadowing অধ্যাপক मोहित খেরার of the Scott Department of Urology at Baylor College of Medicine. Amid the usual debates on surgical technique, a session on innovation in men’s health took my attention completely.
For decades the conversation around family planning has been lopsided. Women have borne the brunt of contraceptive choices — the side effects of hormonal pills, the inconvenience of patches, the invasiveness of IUDs. Men have had two options unchanged for generations: a condom, or a vasectomy.
Last week I wrote about the hormonal approach — a progestin-and-testosterone gel now approaching its final trial. This week: the two non-hormonal candidates, which take an entirely different route.
The same caveat applies here, and more strongly. Neither of these is available anywhere in the world, and one of them has never been tested in a human being. They are worth understanding, and they are not worth waiting for if you need contraception now.
1. The Hydrogel: A Reversible Plug Inside the Tube
Imagine a method that mimics the reliability of a vasectomy but comes with an undo switch. That is the promise of an injectable hydrogel being developed as a reversible alternative to the operation.
How It Works
Instead of cutting the vas deferens — the tube carrying sperm from the testicles — a urologist uses a no-scalpel technique to inject a liquid gel directly into the tube. Once inside, the gel reacts with the body’s moisture and swells into a durable, flexible plug. Its pores are far smaller than a sperm cell, so sperm cannot pass through, while the fluid part of the semen flows freely.
Because it blocks the cells but not the fluid, it is intended to avoid the back-pressure discomfort sometimes associated with vasectomy. The gel is designed to biodegrade over time and to be flushed out with a counter-injection, which is what would make it reversible.
What the Human Data Actually Shows
At AUA 2026 we saw data from first-in-human trials across several sites in Australia, following healthy men for one to two years. Every participant was implanted successfully, the urologists were able to locate and inject the tube reliably, men reported being comfortable and satisfied, and the independent safety board found no serious adverse events — the side effects were the mild, expected consequences of any injection, such as minor swelling or bruising, which resolved quickly.
That is a genuinely good result, and it is important to be precise about what it is. This was a first-in-human safety study in a small number of men. Its job was to answer whether the implant can be placed safely, and it answered yes. It was not designed to prove that the hydrogel prevents pregnancy — no couple has yet relied on it as their contraception in a trial — and long-term reversibility in men has not been demonstrated either. Those are the questions the next, much larger studies exist to answer, and plenty of devices have looked excellent at this stage and failed later.
It is also worth saying that the comparison is not with nothing. ভ্যাসেকটমি is a fast, safe, highly effective procedure with decades of data behind it, and microsurgical reversal, while never guaranteed, succeeds more often than most men expect. The hydrogel is trying to beat a good incumbent, not fill a void.
2. The On-Demand Pill: An Off-Switch for Sperm Movement
If the hydrogel is a physical wall, the second idea is an internal switch — an on-demand, non-hormonal pill.
To appreciate why this is a departure, recall how researchers used to think about a male pill: copy the female one, using hormones to shut down sperm production from the brain. Hormones, though, act everywhere. Altering a man’s testosterone can affect libido, mood and weight, and takes months to reverse. The targeted approach is smarter — leave the hormones alone entirely and interfere with a protein that only does a job in the reproductive tract.
Giving Sperm a Dead Battery
Inside every sperm cell sits an enzyme that acts like an ignition switch. When sperm enter the female reproductive tract, this enzyme triggers the chemical burst that makes the tail beat hard enough to swim toward the egg. Block that enzyme temporarily and the sperm loses its power source: it becomes immotile, and cannot reach an egg.
Researchers showcased a compound designed to do exactly this. In animal studies the results were striking: within an hour of dosing, sperm motility dropped to near zero while the animals behaved normally with no hormonal disruption, and full fertility returned within about a day as the drug cleared.
The honest status: this has not been given to humans as a contraceptive. Everything above comes from animal work. The vision of a man taking a pill two hours before intimacy and waking up fully fertile is exactly that — a vision, and a scientifically coherent one, but the gap between an elegant result in animals and a licensed human medicine is where the large majority of drug candidates die. Chemists are still refining these compounds for solubility, stability, a predictable duration and freedom from drug interactions. Human trials come after that.
Why This Matters
This is not only clever chemistry and engineering — it is a shift in how we think about men’s health and partnership. We spend most of our time on restoration: restoring testosterone, treating erectile dysfunction, managing the prostate. Autonomy and shared responsibility belong in that picture too.
If these methods reach the clinic, they would offer:
- A shared burden. Family planning becomes a joint effort rather than a default female responsibility, and long-term hormone exposure is lifted from partners who would rather not carry it.
- Hormones left alone. Because these work mechanically or on a reproductive-tract enzyme, natural testosterone is untouched, at least in principle — human safety data will have to confirm what animal work suggests.
- Flexibility. A long-acting reversible barrier for some men, a pill taken only when needed for others.
One thing neither method would do is protect against sexually transmitted infections. No contraceptive other than a barrier does. Condoms remain the only option that prevents pregnancy and infection at once, and no development described here changes that.
Walking Away From Washington
Shadowing Professor Khera reinforced something about being a physician: mastering today’s tools matters, but so does keeping an eye on what patients will be asking for in five years, so that when they ask you can answer accurately rather than enthusiastically.
The all-or-nothing era of condoms and vasectomy is likely to end within many of our careers. It has not ended yet. When these trials advance, the beneficiaries will be couples who can navigate their reproductive lives as genuine equal partners — and the way to be ready for that is to follow the evidence rather than the headlines.
If you have questions about vasectomy, fertility, contraception, or your reproductive health — the options that exist today — Dr. Soarawee Weerasopone offers specialist men’s health consultations at Bangkok Hospital Headquarters. পরামর্শ বুক করুন. Consultations are also available at Samitivej Sriracha Hospital, Chonburi — please call the department line on 088-022-1445. Questions about the cost of consultation, vasectomy or semen analysis should go to the hospital directly — for Bangkok Hospital, by email to bhquro@bdms.co.th.
ব্যাংকক হসপিটাল টেলিমেডিসিন এমন রোগীদের জন্য উপলব্ধ যারা সশরীরে উপস্থিত হতে পারেন না, যার মধ্যে আন্তর্জাতিক রোগীরাও অন্তর্ভুক্ত — ইউরোলজি বিভাগে ইমেলের মাধ্যমে এটি অগ্রিম ব্যবস্থা করুন bhquro@bdms.co.th. Contraception and vasectomy counselling suit a video consultation well, particularly when a couple wants to talk it through together; examination, semen analysis and any procedure are done in person. Samitivej Sriracha is in-person only.
প্রায়শই জিজ্ঞাসিত প্রশ্ন
What is non-hormonal male contraception?
Non-hormonal male contraception aims to prevent pregnancy without altering a man’s hormones. Instead of suppressing sperm production through the brain, these methods either physically block sperm from leaving the body or temporarily stop sperm from swimming. Because they leave testosterone untouched, they are expected to avoid side effects such as reduced libido, mood changes, or fatigue. Two leading candidates discussed at AUA 2026 are an injectable reversible gel and an on-demand pill, both still in development.
How is the male contraceptive hydrogel different from a vasectomy?
Both aim to block sperm travelling through the vas deferens, but a vasectomy permanently cuts and seals the tube, while the hydrogel is a soft gel injected without a scalpel that forms a plug. The gel is designed to block sperm cells while still letting fluid pass, which should avoid back-pressure discomfort, and to be reversible by breaking down over time or being flushed out with a counter-injection. The important difference today is evidence: vasectomy has decades of data, while the hydrogel has completed only first-in-human safety testing.
How would an on-demand male contraceptive pill work?
It would temporarily block an enzyme inside sperm cells that they need in order to swim. Without it, sperm become immotile and cannot reach an egg. In animal studies the effect began within about an hour and wore off within roughly a day as the drug cleared, without any hormonal disruption. The concept is that a man could take a pill shortly before intimacy and be fertile again the next day. This has not yet been tested in humans.
Would non-hormonal male contraception affect testosterone or sex drive?
That is the design intention, and it is a reasonable expectation. Because these approaches work mechanically, in the case of the gel, or on an enzyme found only in the reproductive tract, in the case of the pill, they should leave natural testosterone untouched, so libido, energy, mood and muscle mass would be unaffected. It is worth being precise, though: this is what the mechanism predicts and what animal work supports, not something established by long-term human experience, because that experience does not exist yet.
Do these methods protect against STIs?
No. Neither the hydrogel nor an on-demand pill would offer any protection against sexually transmitted infections, and the same is true of every hormonal contraceptive for men or women. Condoms remain the only method that prevents both pregnancy and infection. Anyone with new or multiple partners should continue to use them whatever else is being used for contraception.
Are these male contraceptives available yet?
No. Neither is approved or available in any country, including Thailand, and neither can be requested at a clinic. The injectable gel has completed a first-in-human safety trial and still has to demonstrate that it prevents pregnancy and that it reverses reliably in men. The on-demand pill has only been studied in animals. Both are promising, and both must complete years of further trials. For now, condoms and vasectomy remain the established male options.
দাবি পরিত্যাগ This content is written and reviewed by Dr. Soarawee Weerasopone, a board-certified urologist at Bangkok Hospital Headquarters. It is intended for educational purposes only and does not constitute medical advice. The methods described are investigational, are not approved for use in any country, and cannot be provided in Thailand. Medical advice, diagnosis and prescriptions are not provided through personal messaging channels or social media. Always consult a qualified healthcare professional before making any decisions about contraception or fertility.
চিকিৎসাগতভাবে লিখিত এবং পর্যালোচিত: ডা. সোয়ারাওয়ে উইরাসোপোন (ডা. পম) — বোর্ড-সার্টিফাইড ইউরোলজিস্ট, ব্যাংকক হসপিটাল হেডকোয়ার্টার্স, ২০১৬ সাল থেকে ইউরোলজিক্যাল অনুশীলনে যুক্ত। ফেলোশিপ: রোবটিক সার্জারি, চাং গুং মেমোরিয়াল হসপিটাল, তাইওয়ান (২০১৯) · অবসভারশিপ: এন্ডোইউরোলজি, জেনতেনদো ইউনিভার্সিটি হসপিটাল, টোকিও (২০২২) · রিসার্চ স্কলার ও ক্লিনিক্যাল অবসভার, স্কট ডিপার্টমেন্ট অব ইউরোলজি, বেলোর কলেজ অব মেডিসিন, যুক্তরাষ্ট্র (২০২৫–২০২৬)।.

ডাঃ সোআরাবী বীরাসোপোন (ডাঃ পম) Bangkok Hospital Headquarters-এর একজন বোর্ড-সার্টিফাইড ইউরোলজিস্ট, যিনি পুরুষ স্বাস্থ্য, রোবোটিক সার্জারি (da Vinci Xi) এবং কিডনি পাথরের চিকিৎসায় বিশেষজ্ঞ। তিনি ২০১৯ সালে তাইওয়ানের Chang Gung Memorial Hospital-এ অ্যান্ড্রোলজি এবং রোবোটিক সার্জারি ও মিনিমালি ইনভেসিভ ইউরোলজিতে দুটি ক্লিনিক্যাল ফেলোশিপ, টোকিওর Juntendo University Hospital-এ একটি এন্ডোইউরোলজি অবজারভারশিপ (২০২২), এবং বেলর কলেজ অফ মেডিসিনের স্কট ডিপার্টমেন্ট অফ ইউরোলজিতে অধ্যাপক মোহিত খেরার অধীনে রিসার্চ স্কলার ও ক্লিনিক্যাল অবজার্ভার পদ (২০২৫–২০২৬) সম্পন্ন করেছেন।

